GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » Cash Flow from Financing

Mediclinic International (Mediclinic International) Cash Flow from Financing : $-284 Mil (TTM As of Sep. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2022, Mediclinic International paid $0 Mil more to buy back shares than it received from issuing new shares. It spent $88 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $25 Mil paying cash dividends to shareholders. It spent $18 Mil on other financial activities. In all, Mediclinic International spent $131 Mil on financial activities for the six months ended in Sep. 2022.


Mediclinic International Cash Flow from Financing Historical Data

The historical data trend for Mediclinic International's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International Cash Flow from Financing Chart

Mediclinic International Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -150.84 -44.80 -256.19 -180.31 -196.31

Mediclinic International Semi-Annual Data
Mar13 Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.22 -127.60 -75.55 -123.85 -159.68

Mediclinic International Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Mediclinic International's Cash from Financing for the fiscal year that ended in Mar. 2022 is calculated as:

Mediclinic International's Cash from Financing for the quarter that ended in Sep. 2022 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-284 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mediclinic International  (OTCPK:ANHGY) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Mediclinic International's issuance of stock for the six months ended in Sep. 2022 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Mediclinic International's repurchase of stock for the six months ended in Sep. 2022 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Mediclinic International's net issuance of debt for the six months ended in Sep. 2022 was $-88 Mil. Mediclinic International spent $88 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Mediclinic International's net issuance of preferred for the six months ended in Sep. 2022 was $0 Mil. Mediclinic International paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Mediclinic International's cash flow for dividends for the six months ended in Sep. 2022 was $-25 Mil. Mediclinic International spent $25 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Mediclinic International's other financing for the six months ended in Sep. 2022 was $-18 Mil. Mediclinic International spent $18 Mil on other financial activities.


Mediclinic International Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Mediclinic International's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediclinic International (Mediclinic International) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.

Mediclinic International (Mediclinic International) Headlines